Aeterna Zentaris to Present at Needham Healthcare Conference in New York

Thu Mar 29, 2012 7:30am EDT

* Reuters is not responsible for the content in this press release.

Aeterna Zentaris to Present at Needham Healthcare Conference in New York

PR Newswire

QUÉBEC CITY, March 29, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its President and CEO, Juergen Engel, PhD, will be presenting a corporate overview at the 11th Annual Needham Healthcare Conference on Wednesday, April 4, 2012, at 1:20 pm (Eastern), in the Henry Room of the New York Palace Hotel, in New York City.

A live webcast of this slide presentation will be available on Aeterna Zentaris' website at, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit


Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.